• Publications
  • Influence
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR).
Royal Free Hospital, London, UKIntroductionBackground of the European Liver Transplant RegistrySince 1968 the European Liver Transplant Registry (ELTR) collectsprospectively the data of liverExpand
  • 555
  • 28
Applicability and Results of Maastricht Type 2 Donation After Cardiac Death Liver Transplantation
Maastricht type 2 donation after cardiac death (DCD) donors suffer sudden and unexpected cardiac arrest, typically outside the hospital; they have significant potential to expand the donor pool.Expand
  • 164
  • 16
  • PDF
Liver Transplant Using Donors After Unexpected Cardiac Death: Novel Preservation Protocol and Acceptance Criteria
Donors after cardiac death (DCD) suffer irreversible cardiac arrest prior to donation. We describe our liver transplant experience with DCD whose cardiac arrest is unexpected, not following theExpand
  • 254
  • 14
A randomized trial of normothermic preservation in liver transplantation
Liver transplantation is a highly successful treatment, but is severely limited by the shortage in donor organs. However, many potential donor organs cannot be used; this is because sub-optimalExpand
  • 285
  • 13
  • PDF
Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study.
BACKGROUND Pretransplant renal function is the major determinant of survival after liver transplantation (LTx). Patients with hepatorenal syndrome (HRS) have a poor outcome after LTx compared withExpand
  • 202
  • 13
Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation.
BACKGROUND/AIMS After liver transplantation (LT) infection of the graft with the hepatitis C virus (HCV) is almost universal and chronic hepatitis and cirrhosis develop in a significant proportion ofExpand
  • 312
  • 12
Bacterial translocation of enteric organisms in patients with cirrhosis.
BACKGROUND/AIMS The aim of the study was to investigate the prevalence and associated risk factors for bacterial translocation in patients with cirrhosis, a mechanism involved in the pathogenesis ofExpand
  • 387
  • 11
Ascites after liver transplantation.
Massive ascites after liver transplantation, although uncommon, usually represents a serious adverse event. The pathogenesis of this complication has not been adequately investigated. To determineExpand
  • 72
  • 9
  • PDF
Occult hepatitis C virus infection among hemodialysis patients.
Occult hepatitis C virus (HCV) infection (i.e., detectable HCV-RNA in the liver or peripheral blood mononuclear cells) in the absence of both serum HCV-RNA and anti-HCV antibodies has not beenExpand
  • 111
  • 9
  • PDF
Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study.
BACKGROUND/AIMS Recurrence of hepatitis C after liver transplantation (LT) is universal and may cause premature graft loss. We evaluated the efficacy and safety of antiviral therapy in HCV-infectedExpand
  • 183
  • 8